Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics

被引:211
作者
Carlesso, N
Aster, JC
Sklar, J
Scadden, DT
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Expt Hematol, Boston, MA USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA USA
[3] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
关键词
D O I
10.1182/blood.V93.3.838.403k29_838_848
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematopoiesis is a balance between proliferation and differentiation that may be modulated by environmental signals, Notch receptors and their ligands are highly conserved during evolution and have been shown to regulate cell fate decisions in multiple developmental systems. To assess whether Notch1 signaling may regulate human hematopoiesis to maintain cells in an immature state, we transduced a vesicular stomatitis virus G-protein (VSV-G) pseudo-typed bicistronic murine stem cell virus (MSCV)-based retroviral vector expressing a constitutively active form of Notch1 (ICN) and green fluorescence protein into the differentiation competent HL-60 cell line and primary cord blood-derived CD34(+) cells. In addition, we observed endogenous Notch1 expression on the surface of both HL-60 cells and primary CD34(+) cells, and therefore exposed cells to Notch ligand Jagged2, expressed on NIH3T3 cells. Both ligand-independent and ligand-dependent activation of Notch resulted in delayed acquisition of differentiation markers by HL-60 cells and cord blood CD34(+) cells. In addition, primary CD34(+) cells retained their ability to form immature colonies, colony-forming unit-mix (CFU-mix), whereas control cells lost this capacity. Activation of Notch1 correlated with a decrease in the fraction of HL-60 cells that were in G(0)/G(1) phase before acquisition of a mature cell phenotype. This enhanced progression through G(1) was noted despite preservation of the proliferative rate of the cells and the overall length of the cell cycle. These findings show that Notch1 activation delays human hematopoietic differentiation and suggest a link of Notch differentiation effects with altered cell cycle kinetics. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:838 / 848
页数:11
相关论文
共 49 条
  • [1] NOTCH SIGNALING
    ARTAVANISTSAKONAS, S
    MATSUNO, K
    FORTINI, ME
    [J]. SCIENCE, 1995, 268 (5208) : 225 - 232
  • [2] Aster JC, 1997, J BIOL CHEM, V272, P11336
  • [3] Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34(+)CD38(-) bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin
    Borge, OJ
    Ramsfjell, V
    Cui, L
    Jacobsen, SEW
    [J]. BLOOD, 1997, 90 (06) : 2282 - 2292
  • [4] Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2
    Capobianco, AJ
    Zagouras, P
    Blaumueller, CM
    ArtavanisTsakonas, S
    Bishop, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) : 6265 - 6273
  • [5] Chitnis A, 1996, DEVELOPMENT, V122, P2295
  • [6] Christensen S, 1996, DEVELOPMENT, V122, P1373
  • [7] XOTCH, THE XENOPUS HOMOLOG OF DROSOPHILA-NOTCH
    COFFMAN, C
    HARRIS, W
    KINTNER, C
    [J]. SCIENCE, 1990, 249 (4975) : 1438 - 1441
  • [8] ANALYSIS OF MUTATION IN HUMAN-CELLS BY USING AN EPSTEIN-BARR-VIRUS SHUTTLE SYSTEM
    DUBRIDGE, RB
    TANG, P
    HSIA, HC
    LEONG, PM
    MILLER, JH
    CALOS, MP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (01) : 379 - 387
  • [9] TAN-1, THE HUMAN HOMOLOG OF THE DROSOPHILA NOTCH GENE, IS BROKEN BY CHROMOSOMAL TRANSLOCATIONS IN T-LYMPHOBLASTIC NEOPLASMS
    ELLISEN, LW
    BIRD, J
    WEST, DC
    SORENG, AL
    REYNOLDS, TC
    SMITH, SD
    SKLAR, J
    [J]. CELL, 1991, 66 (04) : 649 - 661
  • [10] EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON NORMAL AND MALIGNANT MYELOID CELLS
    GRIFFIN, JD
    RITZ, J
    NADLER, LM
    SCHLOSSMAN, SF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) : 932 - 941